ARNA earnings call for the period ending March 31, 2019.
News & Analysis: Arena Pharmaceuticals
ARNA earnings call for the period ending December 31, 2018.
These biotech upstarts have deep pockets and late-stage pipelines that could make them savvy buys.
Smart strategic moves helped these stocks gain ground.
The company moved to immediately monetize a promising drug candidate. For a cool $800 million up-front payment, investors can't complain.
There's good reason to consider buying shares in these biotech companies soon.
It's all about the pipeline.
Huge gains from small biotechs. But can their momentum continue?
A showdown is brewing between these two biotech companies.
Arena Pharmaceuticals has turned its bad luck around, and could be on the path to something huge.